Shenzhen Loga Tech LG LOGA Semaglutide

As of 9 Aug 2026, Finnrick has published 4 independent lab tests of Semaglutide from Shenzhen Loga Tech LG LOGA: 3 passed and 1 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 17 Dec 2025. The current Finnrick rating for Shenzhen Loga Tech LG LOGA Semaglutide is 70%.

Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.

Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.

Published lab tests of Semaglutide from Shenzhen Loga Tech LG LOGA, newest first.
DateResultCertificate
17 Dec 2025FailCertificate xc2d58z
18 Sep 2025PassCertificate mhy7s76
4 Sep 2025PassCertificate zgmgryn
4 Sep 2025PassCertificate pgw7szr